CellaVision AB (publ) (CLVSF)

Market Cap	426.21M
Revenue (ttm)	79.02M
Net Income (ttm)	15.90M
Shares Out	n/a
EPS (ttm)	0.67
PE Ratio	26.81
Forward PE	23.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	157
Average Volume	535
Open	19.28
Previous Close	19.91
Day's Range	19.28 - 19.28
52-Week Range	19.28 - 25.91
Beta	1.22
RSI	45.66
Earnings Date	Jul 18, 2025

About R1 RCM

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 219
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLVSF

Financial Performance

In 2024, CellaVision AB's revenue was 723.22 million, an increase of 6.78% compared to the previous year's 677.29 million. Earnings were 140.72 million, an increase of 7.99%.